Literature DB >> 8805672

Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response.

R R Caspi1, P B Silver, C C Chan, B Sun, R K Agarwal, J Wells, S Oddo, Y Fujino, F Najafian, R L Wilder.   

Abstract

This study examines whether genetic susceptibility vs genetic resistance to experimental autoimmune uveoretinitis (EAU) are connected to a predisposition to mount a Th1-dominated (IFN-gamma high, IL-4 low) vs a Th2-dominated (IL-4 high, lFN-gamma low) response. Lewis rats developed disease with high incidence after immunization with the uveitogenic peptide R16, whereas F344 rats were resistant. Primed lymph node cells from both strains proliferated in culture in response to R16. However, while the Lewis cultures transferred EAU to syngeneic recipients, those of F344 did not. The Lewis cultures produced substantially more IFN-gamma mRNA and protein in response to R16, than did those of F344. Both strains made low levels of IL-10 mRNA and IL-4 mRNA. Unlike the primary cultures, long-term (R16-specific) T cell lines derived from each of the strains transferred EAU equally well to their respective recipients, and produced similar, high levels of IFN-gamma mRNA and protein. Treatment of F344 with Bordetella pertussis toxin concurrently with immunization abrogated its resistance, enhanced Ag-specific IFN-gamma production in culture, and yielded a primed cell population capable of transferring EAU. Conversely, immunization of Lewis rats with R16 in IFA induced little or no disease; the primed cells produced minimal amounts of IFN-gamma and did not transfer EAU. However, addition of IL-12 into the culture resulted in a highly pathogenic, IFN-gamma-producing cell population. We conclude that genetic susceptibility to ocular autoimmunity in this model is connected to an elevated Th1 response. Genetic resistance, however, does not seem to involve an elevated Th2 response, but rather an inhibited development of Th1-like effector cells.

Entities:  

Mesh:

Year:  1996        PMID: 8805672

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  Immune mechanisms in uveitis.

Authors:  R R Caspi
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Human CD4+ T cell differentiation and effector function: implications for autoimmunity.

Authors:  L S Davis; H Schulze-Koops; P E Lipsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Identification of Th2-type suppressor T cells among in vivo expanded ocular T cells in mice with experimental autoimmune uveoretinitis.

Authors:  H Keino; M Takeuchi; J Suzuki; S Kojo; J Sakai; K Nishioka; T Sumida; M Usui
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

4.  Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.

Authors:  Yong Peng; Gencheng Han; Hui Shao; Yali Wang; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

5.  Rodent models of experimental autoimmune uveitis.

Authors:  Rajeev K Agarwal; Phyllis B Silver; Rachel R Caspi
Journal:  Methods Mol Biol       Date:  2012

Review 6.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

7.  Common genetic determinants of uveitis shared with other autoimmune disorders.

Authors:  Mary J Mattapallil; Azize Sahin; Phyllis B Silver; Shu-Hui Sun; Chi-Chao Chan; Elaine F Remmers; J Fielding Hejtmancik; Rachel R Caspi
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

8.  Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells.

Authors:  M A Frassanito; R Dammacco; T Fusaro; A Cusmai; S Guerriero; C Sborgia
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

9.  Differentially expressed genes in MHC-compatible rat strains that are susceptible or resistant to experimental autoimmune uveitis.

Authors:  Mary J Mattapallil; Andrea Augello; Chris Cheadle; Diane Teichberg; Kevin G Becker; Chi-Chao Chan; Joseph J Mattapallil; Giuseppina Pennesi; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02-15       Impact factor: 4.799

10.  Administration of Mycobacterium leprae rHsp65 aggravates experimental autoimmune uveitis in mice.

Authors:  Eliana B Marengo; Alessandra Gonçalves Commodaro; Jean Pierre S Peron; Luciana V de Moraes; Fernanda C V Portaro; Rubens Belfort; Luiz Vicente Rizzo; Osvaldo Augusto Sant'Anna
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.